Editorial Policy
This page describes the rules the articles and the glossary on ForMyGluco are produced under. Who publishes them is answered on the About page: I am an independent, one-person developer, and I am not a physician.
The sourcing rule
An article without sources does not get published. This is not a statement of intent but a rule enforced at build time: the site's build command runs the checker first, and if the rule is broken the site does not build at all.
Measured across the 94 articles currently published:
- Articles without sources: 0
- Sources per article: minimum 3, median 5, maximum 6
- Total citations: 431
Every article must carry at least one primary source. What counts as primary is defined by name; the main ones are PubMed, PubMed Central, NCBI, Cochrane, the WHO, NICE, ADA, EASD, IDF, KDIGO, the Turkish national guidelines (TEMD, KEDD, the Turkish Diabetes Foundation) and peer-reviewed journals (Diabetes Journals, The Lancet, NEJM, BMJ, JAMA, Wiley). An article resting only on news sites or content farms does not pass the checker.
The same source cannot be listed twice in one article, and citations carry a DOI or a permanent address.
Every source is listed on one page, grouped by institution: Source index. That page is generated from the data too, not kept by hand.
Sentences that will not be written
ForMyGluco is a logging app, not a medical device. That distinction is not a slogan but a legal boundary: under EU medical device law a product's "intended purpose" is determined by the claims made in its promotional material, and a blog is promotional material in the legal sense. So phrasings that amount to a dose, a treatment change, a diagnosis or a promise of cure are forbidden, and nine separate patterns are searched for at build time.
The articles do not say "do this"; they say "under this criterion this threshold is used". The decision belongs to the reader and their doctor.
Languages and translation
Articles are published in Turkish, English, Russian and Arabic; the glossary in Turkish, English and Russian. Where a language has no version yet, the reader is sent to English.
Translations are not published as raw machine output. Two separate checks apply, and they look at different things:
- Structural parity is enforced by a build gate: every translation must have a canonical counterpart, addresses must be unique and ASCII, and title and intro lengths must stay within band. If anything is missing the site does not build.
- Fidelity of meaning cannot be measured mechanically; it is handled in a separate review pass. Topics are not varied by country: the same article, the same content, published in translation.
The glossary
The glossary holds 83 terms. Terms are not cited individually; the glossary as a whole rests on seven institutional sources, listed on the glossary page. Definitions explain what a word means, not what to do about it.
What we do not do
This section matters as much as the ones above.
- Articles are not reviewed by a physician. There is no "medically reviewed" badge on this site, deliberately. Carrying such a badge without earning it misleads the reader.
- We make no clinical claims. There is no claim that the app improves any outcome; such a claim would require a study, and there is none.
- We publish no user testimonials. There is no surface on this site for experience sharing or satisfaction statements.
- There is no sponsored content. No payment has been taken for any article, and there is no arrangement with any institution, device or drug.
Updates, archive and corrections
Articles are informational and can age. Articles withdrawn from publication are not deleted; their addresses keep working, they are only marked as not to be indexed by search engines. There are 63 articles in that state today.
If you find a factual error, a stale source or a broken translation, tell me: support@formygluco.app. It gets corrected.
If a text here contradicts what your doctor tells you, your doctor is right.